Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2220993 | 0.87 | ALDH1A1 (0.62) | ALDH1A1TSHR | |
| SCHEMBL18098051 | 0.87 | ALDH1A1 (0.46) | ALDH1A1 | |
| SCHEMBL1922429 | 0.82 | ALDH1A1 (0.50) | ALDH1A1TSHR | |
| SCHEMBL16541056 | 0.81 | ALDH1A1 (0.54) | ALDH1A1 | |
| SCHEMBL715313 | 0.81 | ALDH1A1 (0.54) | ALDH1A1 | |
| SCHEMBL13928058 | 0.81 | ALDH1A1 (0.54) | ALDH1A1TSHR | |
| SCHEMBL15868744 | 0.79 | ALDH1A1 (0.52) | ALDH1A1 | |
| SCHEMBL4649499 | 0.79 | ALDH1A1 (0.52) | ALDH1A1 | |
| SCHEMBL17636285 | 0.78 | ALDH1A1 (0.42) | ALDH1A1TSHR | |
| SCHEMBL8277378 | 0.78 | ALDH1A1 (0.71) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8658818-B2 | Methods of producing nitrate esters | ALLIANT TECHSYSTEMS INC. (US) | 2014-02-25 | — | — | US | disclosed |
| US-20120130115-A1 | METHODS OF PRODUCING NITRATE ESTERS | ALLIANT TECHSYSTEMS INC. (US) | 2012-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120130115-A1 | METHODS OF PRODUCING NITRATE ESTERS | TST, GMNN, TTN | ALDH1A1 954/4885TSHR 3264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.